These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 8703368

  • 1. Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.
    Hong SI, Park IC, Son YS, Lee SH, Kim BG, Lee JI, Lee TW, Kook YH, Min YI, Hong WS.
    J Korean Med Sci; 1996 Feb; 11(1):33-7. PubMed ID: 8703368
    [Abstract] [Full Text] [Related]

  • 2. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
    Kaneko T, Konno H, Baba M, Tanaka T, Nakamura S.
    Cancer Sci; 2003 Jan; 94(1):43-9. PubMed ID: 12708473
    [Abstract] [Full Text] [Related]

  • 3. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.
    Illemann M, Bird N, Majeed A, Laerum OD, Lund LR, Danø K, Nielsen BS.
    Int J Cancer; 2009 Apr 15; 124(8):1860-70. PubMed ID: 19123477
    [Abstract] [Full Text] [Related]

  • 4. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.
    Scand J Gastroenterol; 2005 Jul 15; 40(7):783-93. PubMed ID: 16109653
    [Abstract] [Full Text] [Related]

  • 5. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
    Zheng Q, Tang ZY, Xue Q, Shi DR, Song HY, Tang HB.
    J Cancer Res Clin Oncol; 2000 Nov 15; 126(11):641-6. PubMed ID: 11079728
    [Abstract] [Full Text] [Related]

  • 6. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U, Prenzel KL, Baldus SE, Metzger R, Dienes HP, Bollschweiler E, Hoelscher AH, Schneider PM.
    Pancreas; 2008 Mar 15; 36(2):173-7. PubMed ID: 18376309
    [Abstract] [Full Text] [Related]

  • 7. Serine proteinase activation in esophageal cancer.
    Tang WH, Friess H, Kekis PB, Martignoni ME, Fukuda A, Roggo A, Zimmerman A, Büchler MW.
    Anticancer Res; 2001 Mar 15; 21(4A):2249-58. PubMed ID: 11724279
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen Activation System in Rectal Adenocarcinoma.
    Razik E, Kobierzycki C, Grzegrzolka J, Podhorska-Okolow M, Drag-Zalesinska M, Zabel M, Dziegiel P.
    Anticancer Res; 2015 Nov 15; 35(11):6009-15. PubMed ID: 26504024
    [Abstract] [Full Text] [Related]

  • 9. Expression of urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in gastric cancer.
    Kawasaki K, Hayashi Y, Wang Y, Suzuki S, Morita Y, Nakamura T, Narita K, Doe W, Itoh H, Kuroda Y.
    J Gastroenterol Hepatol; 1998 Sep 15; 13(9):936-44. PubMed ID: 9794194
    [Abstract] [Full Text] [Related]

  • 10. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A.
    J Hepatol; 1999 Oct 15; 31(4):703-11. PubMed ID: 10551395
    [Abstract] [Full Text] [Related]

  • 11. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
    Foca C, Moses EK, Quinn MA, Rice GE.
    Gynecol Oncol; 2000 Nov 15; 79(2):244-50. PubMed ID: 11063652
    [Abstract] [Full Text] [Related]

  • 12. Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer.
    Lee KH, Bae SH, Lee JL, Hyun MS, Kim SH, Song SK, Kim HS.
    Oncology; 2004 Nov 15; 66(3):210-7. PubMed ID: 15218312
    [Abstract] [Full Text] [Related]

  • 13. Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role.
    Plebani M, Herszènyi L, Carraro P, De Paoli M, Roveroni G, Cardin R, Tulassay Z, Naccarato R, Farinati F.
    Clin Exp Metastasis; 1997 Jul 15; 15(4):418-25. PubMed ID: 9219730
    [Abstract] [Full Text] [Related]

  • 14. Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.
    Zhang L, Zhao ZS, Ru GQ, Ma J.
    World J Gastroenterol; 2006 Jul 07; 12(25):3970-6. PubMed ID: 16810742
    [Abstract] [Full Text] [Related]

  • 15. Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells.
    Kenny S, Duval C, Sammut SJ, Steele I, Pritchard DM, Atherton JC, Argent RH, Dimaline R, Dockray GJ, Varro A.
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep 07; 295(3):G431-41. PubMed ID: 18599586
    [Abstract] [Full Text] [Related]

  • 16. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.
    J Lab Clin Med; 2004 Aug 07; 144(2):69-77. PubMed ID: 15322501
    [Abstract] [Full Text] [Related]

  • 17. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.
    Iwamoto J, Mizokami Y, Takahashi K, Matsuoka T, Matsuzaki Y.
    Helicobacter; 2008 Jun 07; 13(3):174-82. PubMed ID: 18466392
    [Abstract] [Full Text] [Related]

  • 18. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
    Friess H, Duarte R, Kleeff J, Fukuda A, Tang WH, Graber H, Schilling M, Zimmermann A, Korc M, Büchler MW.
    Surgery; 1998 Jul 07; 124(1):79-86. PubMed ID: 9663255
    [Abstract] [Full Text] [Related]

  • 19. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
    Ulisse S, Baldini E, Sorrenti S, Barollo S, Gnessi L, Catania A, Pellizzo MR, Nardi F, Mian C, De Antoni E, D'Armiento M, Frati L.
    J Clin Endocrinol Metab; 2011 Feb 07; 96(2):504-8. PubMed ID: 21106716
    [Abstract] [Full Text] [Related]

  • 20. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.
    Invest Ophthalmol Vis Sci; 2005 Apr 07; 46(4):1364-70. PubMed ID: 15790903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.